NanoViricides Inc (NNVC)

Healthcare | Biotechnology
Income Statement (Quarterly) 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue 0 0 0 0
Cost of Revenue 0 0 0 190,603
Gross Profit 0 0 0 -190,603
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 966,905 902,700 1,234,743 1,209,269
Operating Expenses 2,249,156 2,059,051 3,167,834 2,391,361
Operating Income -2,249,156 -2,059,051 -3,167,834 -2,391,361
Interest Expense 0 149 0 0
Income Before Tax -2,216,783 -2,027,491 -3,126,811 -2,355,987
Income Tax Expense 0 0 0 0
Net Income -2,216,783 -2,027,491 -3,126,811 -2,355,987
Per Share
EPS -0.14 -0.14 -0.23 -0.20
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Revenue 0 0 0 0 0
Cost of Revenue 0 759,014 747,529 723,325 0
Gross Profit 0 -759,014 -747,529 -723,325 0
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 4,042,544,000,000 3,078,814 2,551,054 2,328,737 2,629,565
Operating Expenses 9,591,645,000,000 8,516,111 8,943,468 8,113,599 8,744,106
Operating Income -9,591,645,000,000 -8,516,111 -8,943,468 -8,113,599 -8,744,106
Interest Expense 149,000,000 49,808 938 5,123 85,405
Income Before Tax -9,466,966,000,000 -8,294,146 -8,588,573 -8,106,863 -8,822,189
Income Tax Expense 0 0 355,833 -6,736 0
Net Income -9,466,966,000,000 -8,294,146 -8,588,573 -8,100,127 -8,822,189
Per Share
EPS -0.63 -0.70 -0.74 -0.70 -0.81
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Assets
Cash and Cash Equivalents 1,558,564,000,000 4,797,778 8,149,808 14,066,359
Short Term Investments 0 0 0 0
Net Receivables 0 0 0 0
Inventory 0 0 0 0
Total Current Assets 1,670,710,000,000 4,970,520 8,445,294 14,416,380
Property Plant Equipment 6,833,891,000,000 7,512,463 8,106,647 8,694,194
Goodwill and Intangibles 317,039,000,000 325,308 333,578 341,848
Total Assets 8,824,085,000,000 12,822,853 16,899,880 23,494,862
Liabilities
Account Payables 459,094,000,000 376,270 157,056 57,960
Short Term Debt 0 0 0 94,788
Total Current Liabilities 1,306,519,000,000 1,358,776 534,250 412,837
Long Term Debt 0 0 0 0
Total Liabilities 1,306,519,000,000 1,358,776 2,034,250 412,837
Shareholders Equity
Retained Earnings -148,841,861,000,000 -139,374,895 -131,080,749 -122,492,176
Total Shareholders Equity 7,517,566,000,000 11,464,077 14,865,630 23,082,025
Balance Sheet (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Assets
Cash and Cash Equivalents 1,558,564,000,000 4,797,778 8,149,808 14,066,359 20,516,677
Short Term Investments 0 0 0 0 0
Net Receivables 0 0 0 0 0
Inventory 0 0 0 0 0
Total Current Assets 1,670,710,000,000 4,970,520 8,445,294 14,416,380 20,823,779
Property Plant Equipment 6,833,891,000,000 7,512,463 8,106,647 8,694,194 9,084,901
Goodwill and Intangibles 317,039,000,000 325,308 333,578 341,848 350,118
Total Assets 8,824,085,000,000 12,822,853 16,899,880 23,494,862 30,262,313
Liabilities
Account Payables 459,094,000,000 376,270 157,056 57,960 231,555
Short Term Debt 0 0 0 94,788 95,306
Total Current Liabilities 1,306,519,000,000 1,358,776 534,250 412,837 351,146
Long Term Debt 0 0 0 0 0
Total Liabilities 1,306,519,000,000 1,358,776 2,034,250 412,837 351,146
Shareholders Equity
Retained Earnings -148,841,861,000,000 -139,374,895 -131,080,749 -122,492,176 -114,385,313
Total Shareholders Equity 7,517,566,000,000 11,464,077 14,865,630 23,082,025 29,911,167
Cash Flow Statement (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Activities
Net Income -9,466,966,000,000 -8,294,146 -8,588,573 -8,106,863
Depreciation & Amortization 735,536,000,000 759,014 747,529 723,325
Stock Based Compensation 60,722,000,000 222,185 214,179 338,418
Change in Working Capital 0 996,877 1,798,815 214,563
Operating Cash Flow -8,478,679,000,000 -6,315,507 -5,670,051 -5,891,254
Investing Activities
Capital Expenditure -56,964,000,000 -156,560 -151,712 -324,348
Investments -56,964,000,000 -156,560 -151,712 -324,348
Investing Cash Flow -56,964,000,000 -156,560 -151,712 -324,348
Financing Activities
Debt Repayment 0 0 -94,788 -234,716
Common Stock Issued/Repurchased 5,296,429,000,000 3,120,037 0 0
Dividends Paid 0 0 0 0
Financing Cash Flow 5,296,429,000,000 3,120,037 -94,788 -234,716
Summary
Free Cash Flow -8,535,643,000,000 -6,472,067 -5,821,763 -6,215,602
Net Change in Cash -3,239,214,000,000 -3,352,030 -5,916,551 -6,450,318
Cash Flow Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Operating Activities
Net Income -9,466,966,000,000 -8,294,146 -8,588,573 -8,106,863 -8,822,189
Depreciation & Amortization 735,536,000,000 759,014 747,529 723,325 704,538
Stock Based Compensation 60,722,000,000 222,185 214,179 338,418 405,594
Change in Working Capital 0 996,877 1,798,815 214,563 -540,112
Operating Cash Flow -8,478,679,000,000 -6,315,507 -5,670,051 -5,891,254 -8,213,837
Investing Activities
Capital Expenditure -56,964,000,000 -156,560 -151,712 -324,348 -238,764
Investments -56,964,000,000 -156,560 -151,712 -324,348 -238,764
Investing Cash Flow -56,964,000,000 -156,560 -151,712 -324,348 -238,764
Financing Activities
Debt Repayment 0 0 -94,788 -234,716 -1,303,013
Common Stock Issued/Repurchased 5,296,429,000,000 3,120,037 0 0 16,563,697
Dividends Paid 0 0 0 0 0
Financing Cash Flow 5,296,429,000,000 3,120,037 -94,788 -234,716 15,260,684
Summary
Free Cash Flow -8,535,643,000,000 -6,472,067 -5,821,763 -6,215,602 -8,452,601
Net Change in Cash -3,239,214,000,000 -3,352,030 -5,916,551 -6,450,318 6,808,083